Two tuberculosis researchers in South Africa, Constance Schreuder and Tatenda Bvudzijena, contracted the disease they study, exposing systemic challenges in TB diagnosis and treatment.Schreuder, a senior medical technologist, tested positive after years of lab work, despite negative initial tests and no symptoms.Her case highlights asymptomatic TB, where the bacteria is active but undetected.Bvudzijena, a PhD student, faced delayed diagnosis due to misdiagnosis as asthma, eventually confirmed by chest X-ray.

Both face six-month treatment regimens with side effects, but access to medication is hindered by bureaucratic delays and resource shortages in public clinics.

Their experiences underscore the gap between scientific research and real-world healthcare delivery, with calls for improved systems to ensure timely treatment and reduce TB transmission.

The article critiques South Africa's TB management, emphasizing the need for better coordination between public and private sectors to address the crisis effectively.